T. Rowe Price Blue Chip Growth Fund Class R

The investment seeks long-term capital growth; income is a secondary objective. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of large and medium-sized blue chip growth companies. It focuses on companies with leading market positions, seasoned management, and strong financial fundamentals. The fund is non-diversified.

T. Rowe Price Blue Chip Growth Fund Class R trades as RRBGX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

T. Rowe Price Blue Chip Growth Fund Class R can be compared against peers such as American Funds AMCAP A, T. Rowe Price Blue Chip Growth Fund Advisor Class, T. Rowe Price Growth Stock Fund I Class, American Funds AMCAP R5, American Funds SMALLCAP World R6, T. Rowe Price Growth Stock Fund R Class.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $94.65B, beta of 1.17, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

RRBGX currently shows total debt of N/A and beta of 1.17. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-05-28 00:00:00), 497 (2026-05-01 00:00:00), 24F-2NT (2026-03-26 00:00:00), 497 (2026-03-25 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.troweprice.com/financial-intermediary/us/en/investments/mutual-funds/us-products/blue-chip-growth-fund/r-class.html

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.